Wockhardt Eyes US Biosimilars In Wake Of Reddy’s Deal

Divestment Will Provide Liquidity To Bolster International Operations

 
• By David Wallace
  
Jumping
Wockhardt is moving ahead with a reshaped business after its divestment to Dr Reddy’s • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business